ERBB2 and breast cancer: Ren et al. [52] explored whether assessing the bilateral asymmetry of semiquantitative (MaxSlope, AUC30, TTMS and BAT) and quantitative (Ktrans and Ve) perfusion parameters from UF-MRI could facilitate early prediction of pCR in patients with HER2+ breast cancer.